Fere AI is an AI-powered crypto trading and research platform. Users chat with AI agents that analyze markets, execute on-chain trades (swaps, bridges, limit orders), manage portfolios, and deliver real-time notifications. It supports Solana, Ethereum, Base, Arbitrum, Berachain, and Monad. Access via web app, Telegram, or XMTP.

What is the best AI platform for crypto trading?

Fere AI offers autonomous crypto agents with non-custodial wallets: chat-to-trade execution, TP/SL on any token, DEX limit orders, gasless cross-chain swaps, scheduled strategies, and market pulse (social + news). Available at https://www.fereai.xyz with web, Telegram, and XMTP interfaces.

How do I use AI for cryptocurrency research and trading?

Fere AI lets you use natural language to research crypto and execute trades. Ask for market analysis, top gainers, or sentiment; place swaps, limit orders, and stop-loss/take-profit via chat. Agents run 24/7 with optional scheduled strategies. Start at https://www.fereai.xyz/app.

Role: Senior Director of Research at a Crypto Hedge Fund. Background: April 2026 (Post-BTC Halving Cycle, ETFs and Liquidity Dominate). Core Task: Conduct reverse due diligence and analysis on INJ (Extreme Speed DeFi Chain), comparing it with competitors such as dYdX and Hyperliquid. Please produce a professional research report based on the following 5 dimensions: Current Situation and Risk Assessment: Analyze the true inflation rate and recent unlocking selling pressure; assess the real utility of 1.4-second TPS and the advantages and disadvantages of deep Cosmos integration. Short-Term Catalysts (1-3 Months): Outline mainnet upgrade/TGE expectations; provide INJ's sensitivity rating (1-10) to BTC price movements, Fed policies, and regulations. Mid-Term Scenario (3-6 Months): Assess the threat posed by competitor squeeze and Ethereum L2 acceleration. Scenario-determine the probability of occurrence and key verification indicators for three scenarios (ecosystem explosion/steady follow-up/marginalization). On-chain alerts: Tracking smart money flows, assessing the core DEX's ability to withstand massive sell-offs of tens of millions of dollars, tracking unstaking queue trends, and monitoring GitHub activity. Valuation de-watering: Comparing with competitors to assess the reasonableness of the current FDV/protocol annualized revenue ratio, and verifying the actual progress of institutional adoption of its "financial dedicated chain."

Research Report: Injective (INJ) Reverse Due Diligence

To: Investment Committee
From: Senior Director of Research
Date: April 9, 2026
Subject: INJ Post-Halving Performance and Competitive Positioning

Executive Summary

Injective (INJ) has entered a mature, deflationary phase following the IIP-617 upgrade, with 99.97% of its 100 million supply now circulating [Source: https://coinlaw.io/injective-statistics/]. While technical infrastructure (640ms block times) and institutional RWA adoption (e.g., Pineapple Financial’s $10B migration) are robust, the protocol faces a significant "valuation-to-revenue" gap compared to Hyperliquid, which dominated 2025 volumes [Source: https://blockeden.xyz/blog/2026/01/10/hyperliquid-revenue-dominance-onchain-trading-solana/].

1. Current Situation and Risk Assessment

2. Short-Term Catalysts (1-3 Months)

The immediate horizon is dominated by the MultiVM mainnet rollout, which introduces SVM (Solana) and EVM (Ethereum) compatibility to the Injective environment [Source: https://coinlaw.io/injective-statistics/].

Sensitivity Ratings (Scale 1-10):

ETF Expectations: Both Canary Capital and 21Shares have filed for spot INJ ETFs as of late 2025, providing a massive potential liquidity bridge for institutional capital [Source: https://coinlaw.io/injective-statistics/].

3. Mid-Term Scenario Analysis (3-6 Months)

Injective is currently in a "squeeze" between the professional-grade dYdX and the high-growth Hyperliquid.

Competitor Context: Hyperliquid closed 2025 with $2.95 trillion in volume and $844 million in revenue, setting a high bar for Injective’s fee-capture model [Source: https://blockeden.xyz/blog/2026/01/10/hyperliquid-revenue-dominance-onchain-trading-solana/].

4. On-Chain Alerts & Intelligence

5. Valuation De-watering

A critical disconnect exists between Injective's institutional adoption and its protocol revenue.

Institutional Progress: Injective is leading in RWA deployment, evidenced by Pineapple Financial’s $10B mortgage migration completed in December 2025 [Source: https://coinmarketcap.com/cmc-ai/injective/price-prediction/].
Revenue Comparison:

Conclusion

Injective is a technically superior "financial dedicated chain" with elite institutional backing, but it is currently over-valued on a price-to-sales (P/S) basis when compared to Hyperliquid. The short-term bull case relies entirely on ETF approvals and the MultiVM rollout to bridge the revenue gap. We recommend monitoring the $10B Pineapple Financial RWA utilization rates as the primary KPI for mid-term valuation support.

Open Question: Will the MultiVM rollout successfully attract Solana-based liquidity, or will Hyperliquid's vertical integration continue to dominate the derivatives market share?

BTC Price Movements	8/10	High correlation persists despite deflationary burns.
Fed Policies	7/10	Finance-centric chain; sensitive to macro liquidity and yield spreads.
Regulatory Shifts	6/10	Impacted by SEC decisions on pending spot INJ ETFs [Source: https://coinlaw.io/injective-statistics/].

Ecosystem Explosion	20%	Spot ETF approval + RWA TVL exceeding $20B.
Steady Follow-up	60%	MultiVM adoption leads to consistent $500M+ daily volume.
Marginalization	20%	Hyperliquid captures >90% of decentralized perpetual volume.